BioSpring
Frankfurt am Main, Germany
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
✓ Press (3)
○ EMA GMP
○ MHRA GMP
Quick Facts: BioSpring
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Frankfurt am Main, Germany
- Website
- https://www.biospring.net/
- Modalities
- Oligonucleotide, mRNA/LNP
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About BioSpring
BioSpring is a contract development and manufacturing organization (CDMO). Capabilities: Oligonucleotide, mRNA/LNP. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.biospring.net/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
BioSpring FDA Inspection History
2022-11
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2022-11-15 |
Biospring Gmbh
Frankfurt am Main
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 3 articles
Company announcements, not verified evidence. They do not change any score.
BioSpring announces €100+m investment in new synthetic nucleic acid facility - European Biotechnology Magazine
Nucleic Acid Therapeutics CDMO Market Size, Share & Growth Graph by 2034 - Straits Research
BioSpring and Pantherna agree on strategic cooperation in the field of genome editing - Drug Discovery News
Frequently Asked Questions About BioSpring
How many FDA inspections does BioSpring have on record?
CDMO Signal tracks 1 FDA inspection for BioSpring, sourced from the FDA inspection database. See the full inspection history above.
Has BioSpring received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for BioSpring.
Does BioSpring have a CDMO Signal Score?
Not yet. BioSpring is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating BioSpring for a manufacturing program?
Use the free AI matchmaker to compare BioSpring against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Axolabs (Nuvisan)
Kulmbach, Germany
Signal Score: 71.8
Oligonucleotide
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 84.8
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 81.1
mRNA, Oligonucleotide, Biologics
Nitto Denko Avecia
Milford, MA
Signal Score: 80.3
Oligonucleotide, mRNA
Compare BioSpring with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.